Cancer Drug Parity Act of 2023
Latest action · Nov 8, 2023 Referred to the House Committee on Education and the Workforce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedNov 8, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Cosponsors 27
Members who signed on, in the order they did. Signatures ran from Nov 8, 2023 to Dec 10, 2024; 6 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Brian Higgins | Original | Nov 8, 2023 |
| R-PA | Brian K. Fitzpatrick | Original | Nov 8, 2023 |
| D-CA | Doris O. Matsui | Original | Nov 8, 2023 |
| R-FL | Gus M. Bilirakis | Original | Nov 8, 2023 |
| D-NY | Joseph D. Morelle | Original | Nov 8, 2023 |
| D-OR | Suzanne Bonamici | Original | Nov 8, 2023 |
| D-TX | Colin Z. Allred | Nov 30, 2023 | |
| D-CA | Jimmy Panetta | Nov 30, 2023 | |
| D-CA | Julia Brownley | Nov 30, 2023 | |
| D-NY | Yvette D. Clarke | Dec 5, 2023 | |
| D-VA | Gerald E. Connolly | Dec 11, 2023 | |
| D-FL | Kathy Castor | Dec 11, 2023 | |
| D-MD | David J. Trone | Jan 10, 2024 | |
| D-MD | Jamie Raskin | Jan 10, 2024 | |
| D-CA | Nanette Diaz Barragán | Jan 10, 2024 | |
| D-NH | Ann M. Kuster | Jan 25, 2024 | |
| D-CA | Grace F. Napolitano | Mar 12, 2024 | |
| D-NH | Chris Pappas | May 22, 2024 | |
| R-FL | Bill Posey | Jun 27, 2024 | |
| D-WA | Derek Kilmer | Jun 27, 2024 | |
| D-CO | Yadira Caraveo | Jul 23, 2024 | |
| D-WI | Gwen Moore | Oct 15, 2024 | |
| D-CA | Ted Lieu | Oct 15, 2024 | |
| D-CT | John B. Larson | Oct 22, 2024 | |
| D-NC | Donald G. Davis | Oct 25, 2024 | |
| D-VA | Abigail Davis Spanberger | Nov 26, 2024 | |
| D-KS | Sharice Davids | Dec 10, 2024 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Education and Workforce Committee | Referred Nov 8, 2023 |
Actions 2
Everything that happened, newest first.
- Nov 8, 2023Introduced in House
- Nov 8, 2023Referred to the House Committee on Education and the Workforce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 185, November 8, 2023, page H5652.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2039 | Cancer Drug Parity Act of 2023 | Identical bill | Jun 15, 2023 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
- Short Title(s) as Introduced
- Cancer Drug Parity Act of 2023
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Nov 8, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
